Who owns the DESTROYING CANCER AT THE SPEED OF LIGHT trademark?

The DESTROYING CANCER AT THE SPEED OF LIGHT trademark is owned by Theralase Technologies Inc..

What class is the DESTROYING CANCER AT THE SPEED OF LIGHT trademark registered in?

The DESTROYING CANCER AT THE SPEED OF LIGHT trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for DESTROYING CANCER AT THE SPEED OF LIGHT?

The USPTO serial number for DESTROYING CANCER AT THE SPEED OF LIGHT is 90789850.

What is the registration number for DESTROYING CANCER AT THE SPEED OF LIGHT?

DESTROYING CANCER AT THE SPEED OF LIGHT is registered under USPTO registration number 7757215.

DES

USPTO Trademark Record

REGISTERED

DESTROYING CANCER AT THE SPEED OF LIGHT

SN 90789850·Reg 7757215·Filed Jun 23, 2021

Owner Theralase Technologies Inc.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

DESTROYING CANCER AT THE SPEED OF LIGHT (Serial No. 90789850), Registration No. 7757215, is a registered US trademark filed on Jun 23, 2021 by Theralase Technologies Inc.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

early section 8: April 15, 2031

Mark Intelligence

DESTROYING CANCER AT THE SPEED OF LIGHT (Reg. #7757215) is a registered US trademark that has been protecting its owner, Theralase Technologies Inc., since 2021. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Jun 23, 2021

SERIAL

90789850

REG#

7757215

REGISTERED

Apr 15, 2025

Owner

Applicant

Theralase Technologies Inc.

Entity

Corporation

Address

41 Hollinger Road, Toronto, M4B3G4

Country

Attorney

NameDavid M. Tener, Esq.

Law firm

David M. Tener, Esq. CAESAR RIVISE, PC

Docket

T1081/30031

Address

1635 MARKET STREET, 7 PENN CENTER, 12TH FLOOR, PHILADELPHIA, PA 19103, United States

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateJun 23, 2021

Serial Number90789850

Registration No.7757215

Registration DateApr 15, 2025

Status DateApr 15, 2025

Published for OppositionFeb 25, 2025

Mark TypeStandard characters

Attorney DocketT1081/30031

Status DescriptionLive and registered

Filing Signals

FILED

2021

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

29 events

REGISTERED-PRINCIPAL REGISTER

Apr 15, 2025

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Apr 15, 2025

NOTICE OF REGISTRATION CONFIRMATION EMAILED

PUBLISHED FOR OPPOSITION

Feb 25, 2025

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Feb 25, 2025

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Feb 19, 2025

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Feb 04, 2025

APPROVED FOR PUB - PRINCIPAL REGISTER

CORRESPONDENCE RECEIVED IN LAW OFFICE

Feb 03, 2025

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Feb 03, 2025

TEAS/EMAIL CORRESPONDENCE ENTERED

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

Jan 31, 2025

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

SUSPENSION INQUIRY WRITTEN

Nov 20, 2024

SUSPENSION INQUIRY WRITTEN

INQUIRY TO SUSPENSION E-MAILED

Nov 20, 2024

INQUIRY TO SUSPENSION E-MAILED

NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED

Nov 20, 2024

NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED

Jan 09, 2024

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED

SUSPENSION LETTER WRITTEN

Jul 12, 2023

SUSPENSION LETTER WRITTEN

LETTER OF SUSPENSION E-MAILED

Jul 12, 2023

LETTER OF SUSPENSION E-MAILED

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

Jul 12, 2023

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

ASSIGNED TO LIE

Jul 11, 2023

ASSIGNED TO LIE

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jul 11, 2023

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Jul 11, 2023

TEAS/EMAIL CORRESPONDENCE ENTERED

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

Mar 10, 2023

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

SUSPENSION INQUIRY WRITTEN

Sep 14, 2022

SUSPENSION INQUIRY WRITTEN

INQUIRY TO SUSPENSION E-MAILED

Sep 14, 2022

INQUIRY TO SUSPENSION E-MAILED

NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED

Sep 14, 2022

NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED

SUSPENSION LETTER WRITTEN

Mar 17, 2022

SUSPENSION LETTER WRITTEN

LETTER OF SUSPENSION E-MAILED

Mar 17, 2022

LETTER OF SUSPENSION E-MAILED

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

Mar 17, 2022

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

ASSIGNED TO EXAMINER

Mar 15, 2022

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Sep 08, 2021

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Jun 26, 2021

NEW APPLICATION ENTERED

DESTROYING CANCER AT THE SPEED OF LIGHT

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by Theralase Technologies Inc.

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by David M. Tener, Esq.

Resources

Company